All News

How Biomarkers May Help Guide Kidney Cancer Treatment Earlier

August 8th 2025, 1:00pm

Video

Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.

Please Don’t Call Me ‘Dear’: A Poem From Cancer Treatment

August 7th 2025, 9:00pm

Article

I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being truly seen.

Mom Supports Other Parents After Daughter’s Bone Cancer Diagnosis

August 7th 2025, 7:00pm

Article

Dena Paluck became a mentor to other parents after guiding her daughter through osteosarcoma treatment and feeling isolated during the process.

A Letter to My Support System

August 7th 2025, 5:00pm

Article

I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.

Zusduri Shows Durable Response in Non–Muscle-Invasive Bladder Cancer

August 7th 2025, 4:00pm

Article

In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.

AI May Better Predict Cancer Biomarkers and Patient Survival

August 7th 2025, 3:00pm

Article

An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.

The Importance of Expert Opinions After a GIST Diagnosis

August 7th 2025, 1:00pm

Video

Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, according to Dr. Weijing Sun.

Survivor Builds Support Network for Women With Cancer

August 6th 2025, 9:00pm

Article

Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, self-advocacy and healing.

Finishing Chemo with Stage 4 Lung Cancer: Facing Hope and Uncertainty

August 6th 2025, 8:00pm

Video

In an interview with CURE, Clara Cirks shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings.

FDA Approves Modeyso for Patients with Diffuse Midline Glioma

August 6th 2025, 6:55pm

Article

The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.